BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;6:936-946. [PMID: 17128210 DOI: 10.1038/nrc2014] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS. Gastrokine 1 inhibits gastrin-induced cell proliferation. Gastric Cancer 2016;19:381-91. [PMID: 25752269 DOI: 10.1007/s10120-015-0483-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Takamura A, Ito M, Boda T, Matsumoto Y, Tanaka S, Yoshihara M, Chayama K. High expression of gastrin receptor protein in injured mucosa of Helicobacter pylori-positive gastritis. Dig Dis Sci 2013;58:634-40. [PMID: 23053898 DOI: 10.1007/s10620-012-2427-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
3 Yu G, Wang W, Wang X, Xu M, Zhang L, Ding L, Guo R, Shi Y. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis. BMC Complement Altern Med 2018;18:292. [PMID: 30382864 DOI: 10.1186/s12906-018-2356-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 15.7] [Reference Citation Analysis]
4 Matsuo J, Kimura S, Yamamura A, Koh CP, Hossain MZ, Heng DL, Kohu K, Voon DC, Hiai H, Unno M, So JB, Zhu F, Srivastava S, Teh M, Yeoh KG, Osato M, Ito Y. Identification of Stem Cells in the Epithelium of the Stomach Corpus and Antrum of Mice. Gastroenterology 2017;152:218-231.e14. [PMID: 27670082 DOI: 10.1053/j.gastro.2016.09.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 13.6] [Reference Citation Analysis]
5 Kim HJ, Kang TW, Haam K, Kim M, Kim SK, Kim SY, Lee SI, Song KS, Jeong HY, Kim YS. Whole genome MBD-seq and RRBS analyses reveal that hypermethylation of gastrointestinal hormone receptors is associated with gastric carcinogenesis. Exp Mol Med. 2018;50:156. [PMID: 30510283 DOI: 10.1038/s12276-018-0179-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wan B, Wang X, Zhou Y, Zhang X, Huo K, Han Z. C12ORF39, a novel secreted protein with a typical amidation processing signal. Bioscience Reports 2010;30:1-10. [DOI: 10.1042/bsr20080156] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
7 Selvik LK, Fjeldbo CS, Flatberg A, Steigedal TS, Misund K, Anderssen E, Doseth B, Langaas M, Tripathi S, Beisvag V, Lægreid A, Thommesen L, Bruland T. The duration of gastrin treatment affects global gene expression and molecular responses involved in ER stress and anti-apoptosis. BMC Genomics 2013;14:429. [PMID: 23805861 DOI: 10.1186/1471-2164-14-429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
8 Chen QF, Zhou XD, Fang DH, Zhang EG, Lin CJ, Feng XZ, Wang N, Wu JS, Wang D, Lin WH. Helicobacter pylori infection with atrophic gastritis: An independent risk factor for colorectal adenomas. World J Gastroenterol 2020; 26(37): 5682-5692 [PMID: 33088161 DOI: 10.3748/wjg.v26.i37.5682] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sáenz JB, Mills JC. Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 2018;15:257-73. [PMID: 29463907 DOI: 10.1038/nrgastro.2018.5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
10 Rehfeld JF, Bundgaard JR. Cell-Specific Precursor Processing. In: Rehfeld JF, Bundgaard JR, editors. Cellular Peptide Hormone Synthesis and Secretory Pathways. Berlin: Springer Berlin Heidelberg; 2010. pp. 185-205. [DOI: 10.1007/400_2009_32] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhao N, Zhang W, Guo Y, Jia H, Zha Q, Liu Z, Xu S, Lu A. Effects on neuroendocrinoimmune network of Lizhong Pill in the reserpine induced rats with spleen deficiency in traditional Chinese medicine. J Ethnopharmacol. 2011;133:454-459. [PMID: 20951788 DOI: 10.1016/j.jep.2010.10.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
12 Marshall KM, Laval M, Estacio O, Hudson DF, Kalitsis P, Shulkes A, Baldwin GS, Patel O. Activation by zinc of the human gastrin gene promoter in colon cancer cells in vitro and in vivo. Metallomics 2015;7:1390-8. [PMID: 26404630 DOI: 10.1039/c5mt00147a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Kovac S, Anderson GJ, Baldwin GS. Gastrins, iron homeostasis and colorectal cancer. Biochim Biophys Acta 2011;1813:889-95. [PMID: 21320535 DOI: 10.1016/j.bbamcr.2011.02.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
14 Verbeure W, van Goor H, Mori H, van Beek AP, Tack J, van Dijk PR. The Role of Gasotransmitters in Gut Peptide Actions. Front Pharmacol 2021;12:720703. [PMID: 34354597 DOI: 10.3389/fphar.2021.720703] [Reference Citation Analysis]
15 Giraud AS, Judd LM. Genetic Models of Gastric Cancer in the Mouse. In: Wang TC, Fox JG, Giraud AS, editors. The Biology of Gastric Cancers. New York: Springer; 2009. pp. 483-512. [DOI: 10.1007/978-0-387-69182-4_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Lee JY, Park HW, Choi JY, Lee JS, Koo JE, Chung EJ, Chang HS, Choe J, Yang DH, Myung SJ, Jung HY, Yang SK, Byeon JS. Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm. Gut Liver. 2016;10:902-909. [PMID: 27458180 DOI: 10.5009/gnl15340] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
17 Kovac S, Loh SW, Lachal S, Shulkes A, Baldwin GS. Bismuth ions inhibit the biological activity of non-amidated gastrins in vivo. Biochem Pharmacol 2012;83:524-30. [PMID: 22172990 DOI: 10.1016/j.bcp.2011.11.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
18 Khan M, Huang T, Lin CY, Wu J, Fan BM, Bian ZX. Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy. Oncotarget 2017;8:104615-37. [PMID: 29262666 DOI: 10.18632/oncotarget.18403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn 2009;3:585-96. [PMID: 23495987 DOI: 10.1517/17530050902862175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Sentani K, Oue N, Noguchi T, Sakamoto N, Matsusaki K, Yasui W. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin. Pathol Int 2010;60:291-7. [PMID: 20403031 DOI: 10.1111/j.1440-1827.2010.02519.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
21 Yin Y, Grabowska AM, Clarke PA, Whelband E, Robinson K, Argent RH, Tobias A, Kumari R, Atherton JC, Watson SA. Helicobacter pylori potentiates epithelial: mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut. 2010;59:1037-1045. [PMID: 20584780 DOI: 10.1136/gut.2009.199794] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
22 Krzysiek-Maczka G, Targosz A, Szczyrk U, Strzałka M, Sliwowski Z, Brzozowski T, Czyz J, Ptak-Belowska A. Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro. Helicobacter 2018;23:e12538. [PMID: 30246423 DOI: 10.1111/hel.12538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
23 Subramaniam D, Ramalingam S, May R, Dieckgraefe BK, Berg DE, Pothoulakis C, Houchen CW, Wang TC, Anant S. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms. Gastroenterology. 2008;134:1070-1082. [PMID: 18395088 DOI: 10.1053/j.gastro.2008.01.040] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
24 Persson C, Inoue M, Sasazuki S, Kurahashi N, Iwasaki M, Ye W, Tsugane S. Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). European Journal of Cancer Prevention 2008;17:345-53. [DOI: 10.1097/cej.0b013e3282f521e4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
25 Przemeck SM, Varro A, Berry D, Steele I, Wang TC, Dockray GJ, Pritchard DM. Hypergastrinemia increases gastric epithelial susceptibility to apoptosis. Regul Pept 2008;146:147-56. [PMID: 17900712 DOI: 10.1016/j.regpep.2007.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
26 Yang F, Xu YL, Zhu RF. Helicobacter pylori infection and the risk of colorectal carcinoma: a systematic review and meta-analysis.Minerva Med. 2019;110:464-470. [PMID: 31368293 DOI: 10.23736/S0026-4806.19.05942-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
27 Vange P, Bruland T, Doseth B, Fossmark R, Sousa MML, Beisvag V, Sørdal Ø, Qvigstad G, Waldum HL, Sandvik AK, Bakke I. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival. PLoS One 2017;12:e0184514. [PMID: 28902909 DOI: 10.1371/journal.pone.0184514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
28 Ryödi E, Metso S, Jaatinen P, Huhtala H, Saaristo R, Välimäki M, Auvinen A. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism. J Clin Endocrinol Metab 2015;100:3710-7. [PMID: 26262435 DOI: 10.1210/jc.2015-1874] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
29 Patel O, Marshall KM, Bramante G, Baldwin GS, Shulkes A. The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway. Regul Pept 2010;165:224-31. [PMID: 20727916 DOI: 10.1016/j.regpep.2010.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
30 Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, You W, Li W, Pan K. Screening for gastric cancer in China: Advances, challenges and visions. Chin J Cancer Res 2021;33:168-80. [PMID: 34158737 DOI: 10.21147/j.issn.1000-9604.2021.02.05] [Reference Citation Analysis]
31 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/s00439-009-0722-x] [Cited by in Crossref: 146] [Cited by in F6Publishing: 142] [Article Influence: 12.2] [Reference Citation Analysis]
32 Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 2007;109:1972-9. [PMID: 17393376 DOI: 10.1002/cncr.22635] [Cited by in Crossref: 90] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
33 Zhou JJ, Chen ML, Zhang QZ, Zao Y, Xie Y. Blocking gastrin and CCK-B autocrine loop affects cell proliferation and apoptosis in vitro. Mol Cell Biochem 2010;343:133-41. [PMID: 20559691 DOI: 10.1007/s11010-010-0507-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
34 Hernández C, Barrachina MD, Cosín-Roger J, Ortiz-Masiá D, Álvarez Á, Terrádez L, Nicolau MJ, Alós R, Esplugues JV, Calatayud S. Progastrin represses the alternative activation of human macrophages and modulates their influence on colon cancer epithelial cells. PLoS One 2014;9:e98458. [PMID: 24901518 DOI: 10.1371/journal.pone.0098458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
35 Laval M, Marshall KM, Sachinidis J, Scott A, Eutick M, Baldwin GS. Complexes of gastrin with In3+, Ru3+ or Ga3+ ions are not recognised by the cholecystokinin 2 receptor. J Biol Inorg Chem 2017;22:999-1006. [PMID: 28702751 DOI: 10.1007/s00775-017-1478-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Murphy G, Kamangar F, Dawsey SM, Stanczyk FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Albanes D, Freedman ND. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst 2011;103:1123-9. [PMID: 21693726 DOI: 10.1093/jnci/djr194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
37 Han S, Zhuang J, Wu Y, Wu W, Yang X. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites. Cancer Manag Res 2020;12:8703-20. [PMID: 33061569 DOI: 10.2147/CMAR.S268943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Chen J, Gong TT, Wu QJ. Parity and gastric cancer risk: a systematic review and dose-response meta-analysis of prospective cohort studies. Sci Rep 2016;6:18766. [PMID: 26727146 DOI: 10.1038/srep18766] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
39 Smith JP, Nadella S, Osborne N. Gastrin and Gastric Cancer. Cell Mol Gastroenterol Hepatol. 2017;4:75-83. [PMID: 28560291 DOI: 10.1016/j.jcmgh.2017.03.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
40 Fjeldbo CS, Bakke I, Erlandsen SE, Holmseth J, Lægreid A, Sandvik AK, Thommesen L, Bruland T. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G21-33. [DOI: 10.1152/ajpgi.00197.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
41 Ibiza S, Alvarez A, Romero W, Barrachina MD, Esplugues JV, Calatayud S. Gastrin induces the interaction between human mononuclear leukocytes and endothelial cells through the endothelial expression of P-selectin and VCAM-1. Am J Physiol Cell Physiol 2009;297:C1588-95. [PMID: 19812370 DOI: 10.1152/ajpcell.00082.2009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
42 Steigedal TS, Prestvik WS, Selvik LK, Fjeldbo CS, Bruland T, Lægreid A, Thommesen L. Gastrin-induced proliferation involves MEK partner 1 (MP1). In Vitro Cell Dev Biol Anim 2013;49:162-9. [PMID: 23408059 DOI: 10.1007/s11626-013-9588-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
43 Dacha S, Razvi M, Massaad J, Cai Q, Wehbi M. Hypergastrinemia. Gastroenterol Rep (Oxf). 2015;3:201-208. [PMID: 25698559 DOI: 10.1093/gastro/gov004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
44 Cornelio D, Roesler R, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Annals of Oncology 2007;18:1457-66. [DOI: 10.1093/annonc/mdm058] [Cited by in Crossref: 140] [Cited by in F6Publishing: 126] [Article Influence: 10.0] [Reference Citation Analysis]
45 Gilliam AD, Watson SA. G17DT: an antigastrin immunogen for the treatment of gastrointestinal malignancy. Expert Opin Biol Ther 2007;7:397-404. [PMID: 17309331 DOI: 10.1517/14712598.7.3.397] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
46 Park H, Park JJ, Park YM, Baik SJ, Lee HJ, Jung DH, Kim J, Youn YH, Park H. The association between Helicobacter pylori infection and the risk of advanced colorectal neoplasia may differ according to age and cigarette smoking. Helicobacter 2018;23:e12477. [DOI: 10.1111/hel.12477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
47 Boyce M, Thomsen L. Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scand J Gastroenterol. 2015;50:550-559. [PMID: 25665655 DOI: 10.3109/00365521.2015.1009941] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
48 Pritchett NR, Maziarz M, Shu XO, Kamangar F, Dawsey SM, Fan JH, Ji BT, Gao YT, Xiang YB, Qiao YL, Li H, Yang G, Wang SM, Stanczyk FZ, Chow WH, Katki HA, Zheng W, Lan Q, Freedman ND, Rothman N, Abnet CC, Murphy G. Serum ghrelin and esophageal and gastric cancer in two cohorts in China. Int J Cancer 2020;146:2728-35. [PMID: 31351006 DOI: 10.1002/ijc.32597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
49 Wayua C, Low PS. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers. J Nucl Med 2015;56:113-9. [PMID: 25500824 DOI: 10.2967/jnumed.114.144998] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
50 Xiao L, Kovac S, Chang M, Shulkes A, Baldwin GS, Patel O. Induction of gastrin expression in gastrointestinal cells by hypoxia or cobalt is independent of hypoxia-inducible factor (HIF). Endocrinology 2012;153:3006-16. [PMID: 22593272 DOI: 10.1210/en.2011-2069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
51 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
52 Li S, Zhu X, Liu B, Wang G, Ao P. Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer. Oncotarget 2015;6:13607-27. [PMID: 25962957 DOI: 10.18632/oncotarget.3633] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
53 Johnson SM, Evers BM. Translational research in gastric malignancy. Surg Oncol Clin N Am 2008;17:323-40, viii. [PMID: 18375355 DOI: 10.1016/j.soc.2008.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
54 Selgrad M, Bornschein J, Rokkas T, Malfertheiner P. Helicobacter pylori: gastric cancer and extragastric intestinal malignancies. Helicobacter. 2012;17 Suppl 1:30-35. [PMID: 22958153 DOI: 10.1111/j.1523-5378.2012.00980.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
55 Yu S, Yang M, Nam KT. Mouse models of gastric carcinogenesis. J Gastric Cancer. 2014;14:67-86. [PMID: 25061535 DOI: 10.5230/jgc.2014.14.2.67] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
56 Jeong CY, Kim N, Lee HS, Yoon H, Shin CM, Park YS, Kim J, Lee DH. Risk Factors of Multiple Gastric Polyps according to the Histologic Classification: Prospective Observational Cohort Study. Korean J Gastroenterol 2019;74:17. [DOI: 10.4166/kjg.2019.74.1.17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
57 Chan CP, Tsai YT, Chen YL, Hsu YW, Tseng JT, Chuang HY, Shiurba R, Lee MH, Wang JY, Chang WC. Pb2+ induces gastrin gene expression by extracellular signal-regulated kinases 1/2 and transcription factor activator protein 1 in human gastric carcinoma cells. Environ Toxicol 2015;30:129-36. [PMID: 23765435 DOI: 10.1002/tox.21878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
58 Liu Y, Zhu J, Liu J, Ma X, Zhao J, Su Z. Knockdown of Gastrin Promotes Apoptosis of Gastric Cancer Cells by Decreasing ROS Generation. Biomed Res Int 2021;2021:5590037. [PMID: 33937399 DOI: 10.1155/2021/5590037] [Reference Citation Analysis]
59 Grabowska AM, Berry CA, Hughes J, Bushell M, Willis AE, Watson SA. A gastrin transcript expressed in gastrointestinal cancer cells contains an internal ribosome entry site. Br J Cancer 2008;98:1696-703. [PMID: 18392051 DOI: 10.1038/sj.bjc.6604326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
60 Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
61 Tripathi S, Flobak Å, Chawla K, Baudot A, Bruland T, Thommesen L, Kuiper M, Lægreid A. The gastrin and cholecystokinin receptors mediated signaling network: a scaffold for data analysis and new hypotheses on regulatory mechanisms. BMC Syst Biol 2015;9:40. [PMID: 26205660 DOI: 10.1186/s12918-015-0181-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
62 Solowiej J, Chen JH, Zou HY, Grant SK, Murray BW. Substrate-specific conformational regulation of the receptor tyrosine kinase VEGFR2 catalytic domain. ACS Chem Biol 2013;8:978-86. [PMID: 23441851 DOI: 10.1021/cb400040z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
63 Rai R, Chandra V, Tewari M, Kumar M, Shukla HS. Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer. Surg Oncol 2012;21:281-92. [PMID: 22801592 DOI: 10.1016/j.suronc.2012.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
64 Magnan R, Escrieut C, Gigoux V, De K, Clerc P, Niu F, Azema J, Masri B, Cordomi A, Baltas M, Tikhonova IG, Fourmy D. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist. J Am Chem Soc 2013;135:2560-73. [PMID: 23323542 DOI: 10.1021/ja308784w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
65 Sun L, Tu H, Liu J, Gong Y, Xu Q, Jing J, Dong N, Yuan Y. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population. Scand J Gastroenterol. 2014;49:1164-1172. [PMID: 25157583 DOI: 10.3109/00365521.2014.950693] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
66 Selgrad M, Bornschein J, Kandulski A, Hille C, Weigt J, Roessner A, Wex T, Malfertheiner P. Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms. Int J Cancer. 2014;135:1127-1131. [PMID: 24496701 DOI: 10.1002/ijc.28758] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
67 Fourmy D, Gigoux V, Reubi JC. Gastrin in gastrointestinal diseases. Gastroenterology 2011;141:814-818.e1-3. [PMID: 21767507 DOI: 10.1053/j.gastro.2011.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
68 Copps J, Murphy RF, Lovas S. The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers. Protein Pept Lett. 2009;16:1504-1518. [PMID: 20001914 DOI: 10.2174/092986609789839269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
69 Boyce M, Moore AR, Sagatun L, Parsons BN, Varro A, Campbell F, Fossmark R, Waldum HL, Pritchard DM. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. Br J Clin Pharmacol 2017;83:466-75. [PMID: 27704617 DOI: 10.1111/bcp.13146] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
70 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/x00439-009-0722-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Baldwin GS. Gastrins, iron and colorectal cancer. Metallomics 2009;1:370. [DOI: 10.1039/b909112m] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
72 Chen S, Zhong J, Zhou Q, Lu X, Wang L, Si J. The regenerating gene iα is overexpressed in atrophic gastritis rats with hypergastrinemia. Gastroenterol Res Pract 2011;2011:403956. [PMID: 21949663 DOI: 10.1155/2011/403956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
73 Murphy G, Abnet CC, Choo-Wosoba H, Vogtmann E, Weinstein SJ, Taylor PR, Männistö S, Albanes D, Dawsey SM, Rehfeld JF, Freedman ND. Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers. Int J Epidemiol 2017;46:914-23. [PMID: 28369403 DOI: 10.1093/ije/dyx030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
74 Myllyluoma E, Kajander K, Mikkola H, Kyrönpalo S, Rasmussen M, Kankuri E, Sipponen P, Vapaatalo H, Korpela R. Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Dig Liver Dis. 2007;39:516-523. [PMID: 17433799 DOI: 10.1016/j.dld.2007.02.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
75 Alvarez A, Ibiza MS, Andrade MM, Blas-García A, Calatayud S. Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors. J Pharmacol Exp Ther 2007;323:406-13. [PMID: 17652263 DOI: 10.1124/jpet.107.122754] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
76 Kabir S. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter. 2009;14:159-171. [PMID: 19702845 DOI: 10.1111/j.1523-5378.2009.00677.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
77 Bundgaard JR, Rehfeld JF. Posttranslational Processing of Progastrin. In: Rehfeld JF, Bundgaard JR, editors. Cellular Peptide Hormone Synthesis and Secretory Pathways. Berlin: Springer Berlin Heidelberg; 2010. pp. 207-20. [DOI: 10.1007/400_2009_34] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
78 Grabowska AM, Watson SA. Role of gastrin peptides in carcinogenesis. Cancer Lett. 2007;257:1-15. [PMID: 17698287 DOI: 10.1016/j.canlet.2007.06.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
79 Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH. Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog. 2012;51:939-951. [PMID: 21976141 DOI: 10.1002/mc.20865] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]